ClickCease

Tax Incentives for the Pharmaceutical Industry

Find out if you qualify

Ready to get started? Complete the form below, and one of our specialists will contact you.

Pharmaceutical companies operate in a highly regulated, research-driven environment where long development cycles, complex clinical processes, and significant capital investment are the norm. From advancing new therapies and scaling manufacturing capabilities to investing in specialized facilities and technology, these organizations continually face high-cost innovation demands.

KBKG helps pharmaceutical companies identify and maximize tax incentives related to Research and Development (R&D) Tax Credits, Repair vs. Capitalization Review, 179D Tax Deduction, Cost Segregation / Fixed Assets, Negotiated Incentives, IC-DISC, Predominant Use Study, and Transfer Pricing.

Our experienced team works to uncover overlooked deductions and credits, improve cash flow, and help life sciences organizations fully leverage available federal and state tax benefits.

Pharmaceutical Industry Tax Saving Opportunities

Research and Development (R&D) Tax Credit

Federal credit worth approximately 7% to 10% of qualified research expenditures related to designing, developing and improving processes, formulae, and software. State R&D tax credits may also be available, allowing eligible companies to maximize their tax benefits.

Cost Segregation for Buildings & Improvements

Any building acquisition or/and improvements over $1.5M should be reviewed for proper classification of the individual components for tax depreciation.

Repair vs. Capitalization Review §263(a)

Taxpayers often capitalize major building expenditures that could be claimed as current year deductions for repairs and maintenance such as HVAC units, roofs, parking lots and more.

Fixed Asset Review

Evaluating a company's entire fixed asset schedule to identify assets that can be optimized for federal and state tax purposes. Taxpayers utilizing the book method of accounting for tax are not maximizing their available deductions.

179D Incentive for Energy Efficient Buildings

Federal deduction worth up to $5.94/per square foot of energy efficient buildings. Available to architects, engineers, design/build contractors and building owners.

Transfer Pricing

Cross-border transfer prices drive how much income tax a multinational company pays by country. Transfer pricing regulations apply to the intercompany prices of goods, services, royalties, and loans across all industries. Many companies can realize significant tax savings through transfer pricing strategies.

IC-DISC

The IC-DISC is a federal tax incentive that provides significant, permanent tax savings for U.S. companies that export.

Negotiated Incentives

KBKG helps businesses secure and maximize state and local incentive programs that reduce project costs and improve long-term return on investment.

Predominant Use Study

These studies determine the percentage of utilities used in qualifying processes, enabling businesses to claim important sales tax exemptions and reduce operating costs.

Pharmaceutical Industry Tax Insights

MENU
REQUEST A PROPOSAL